Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
- 1 October 2001
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 358 (9290), 1322-1327
- https://doi.org/10.1016/s0140-6736(01)06413-3
Abstract
No abstract availableFunding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (3345-062041)
This publication has 15 references indexed in Scilit:
- Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort studyThe Lancet, 2001
- Management of the Adverse Effects of Antiretroviral Therapy and Medication AdherenceClinical Infectious Diseases, 2000
- The Case for More Cautious, Patient-Focused Antiretroviral TherapyAnnals of Internal Medicine, 2000
- A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndromeAIDS, 2000
- A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapyAIDS, 1999
- StavudineDrugs, 1999
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Toxicity of antiretroviral agentsAmerican Journal Of Medicine, 1997
- Antibiotic induced fatigue.BMJ, 1993
- Zidovudine: Five Years LaterAnnals of Internal Medicine, 1992